India · Delayed Price · Currency is INR Gufic Biosciences Statistics
Total Valuation
NSE:GUFICBIO has a market cap or net worth of INR 43.81 billion. The enterprise value is 47.24 billion.
| Market Cap | 43.81B |
| Enterprise Value | 47.24B |
Important Dates
The next estimated earnings date is Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | Aug 28, 2026 |
Share Statistics
| Current Share Class | 100.28M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 43.31% |
| Owned by Institutions (%) | 6.95% |
| Float | 25.86M |
Valuation Ratios
The trailing PE ratio is 59.64.
| PE Ratio | 59.64 |
| Forward PE | n/a |
| PS Ratio | 4.47 |
| PB Ratio | 6.59 |
| P/TBV Ratio | 6.65 |
| P/FCF Ratio | 313.89 |
| P/OCF Ratio | 97.06 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 28.34, with an EV/FCF ratio of 338.44.
| EV / Earnings | 64.31 |
| EV / Sales | 4.81 |
| EV / EBITDA | 28.34 |
| EV / EBIT | 35.30 |
| EV / FCF | 338.44 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.61 |
| Debt / EBITDA | 2.43 |
| Debt / FCF | 29.00 |
| Interest Coverage | 3.80 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 9.82% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 4.24% |
| Revenue Per Employee | 6.11M |
| Profits Per Employee | 457,107 |
| Employee Count | 1,607 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:GUFICBIO has paid 258.59 million in taxes.
| Income Tax | 258.59M |
| Effective Tax Rate | 26.04% |
Stock Price Statistics
The stock price has increased by +15.88% in the last 52 weeks. The beta is -0.04, so NSE:GUFICBIO's price volatility has been lower than the market average.
| Beta (5Y) | -0.04 |
| 52-Week Price Change | +15.88% |
| 50-Day Moving Average | 414.42 |
| 200-Day Moving Average | 344.38 |
| Relative Strength Index (RSI) | 52.93 |
| Average Volume (20 Days) | 121,776 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:GUFICBIO had revenue of INR 9.81 billion and earned 734.57 million in profits. Earnings per share was 7.32.
| Revenue | 9.81B |
| Gross Profit | 5.37B |
| Operating Income | 1.34B |
| Pretax Income | 993.14M |
| Net Income | 734.57M |
| EBITDA | 1.60B |
| EBIT | 1.34B |
| Earnings Per Share (EPS) | 7.32 |
Balance Sheet
The company has 621.86 million in cash and 4.05 billion in debt, with a net cash position of -3.43 billion.
| Cash & Cash Equivalents | 621.86M |
| Total Debt | 4.05B |
| Net Cash | -3.43B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 6.65B |
| Book Value Per Share | 66.31 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 451.39 million and capital expenditures -311.81 million, giving a free cash flow of 139.58 million.
| Operating Cash Flow | 451.39M |
| Capital Expenditures | -311.81M |
| Depreciation & Amortization | 261.66M |
| Net Borrowing | 685.59M |
| Free Cash Flow | 139.58M |
| FCF Per Share | n/a |
Margins
Gross margin is 54.77%, with operating and profit margins of 13.64% and 7.49%.
| Gross Margin | 54.77% |
| Operating Margin | 13.64% |
| Pretax Margin | 10.12% |
| Profit Margin | 7.49% |
| EBITDA Margin | 16.31% |
| EBIT Margin | 13.64% |
| FCF Margin | 1.48% |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.02%.
| Dividend Per Share | 0.10 |
| Dividend Yield | 0.02% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.01% |
| Shareholder Yield | 0.03% |
| Earnings Yield | 1.68% |
| FCF Yield | 0.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |